Patricia Carr, VP, Finance & PAO at Jazz Pharmaceuticals plc (JAZZ), sold 138 shares at $124.00 ($17K) on 2020-06-05, disclosed to the SEC on 2020-06-05.
Scheduled sale ($17k) by VP, Finance & PAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |